Manchester University | November 03, 2022
GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, is teaming up with Manchester University (MU) for pharmacogenomics education. Together, GenXys and MU will help drive global awareness and education of PGx-informed prescribing decisions in support of expanding PGx adoption and pending legislation in the U.S., including the Right Drug Dose Now Act. MU, located in northern Indiana, is a leading national academic institution with a strong educational and research stream in pharmacogenetics. With on-campus, online, and dual (PharmD/MS in PGx) degree programs, as well as a Graduate Certificate in PGx, MU typically has an annual PGx enrollment of 60 to 70 students. The partnership will enable GenXys' expertise and proprietary algorithms in genomics and clinical knowledge to support the expansion of genetically informed medication review capabilities in MU's educational and research space. MU will now be able to integrate GenXys' award-winning Clinical Decision Support Systems (CDSS), incorporating PGx with other patient data points through embedded translation and interpretation in specific degree programs. This will lead to students further learning appropriate evidence-based precision prescribing options for patients, ultimately leading to better health outcomes and empowering the next generation of clinicians to seamlessly utilize PGx in patient care. As a national leader in pharmacogenetic and clinical education, Manchester University looks to partner with leading-edge technology companies that further the advancement of PGx for better health outcomes, says David Kisor, PharmD, FCP, Professor of Pharmaceutical Sciences and Pharmacogenomics, Director of Pharmacogenomics at MU. "It is recognized that more than 95 percent of the population has at least one PGx variant, and large percentages of patients receiving medications across therapeutic areas do not respond adequately with an initial medication leading to trial-and-error prescribing. Additionally, the consequences and treatments of adverse drug events may cost more than $30 billion annually in the U.S.," Dr. Kisor adds. "By formally measuring the effect of automatic PGx inclusion in CDSS tools in education as well as incorporating GenXys' precision prescribing platform into our advanced courses, we aim to produce the most knowledgeable and equipped individuals who will apply PGx optimally across healthcare settings. Integration of the precision prescribing platform offered by GenXys into the educational content of MU will accelerate the knowledge uptake of PGx in prescribing decisions for the next generation of clinicians and other healthcare professionals.
"By working with a stellar academic university like MU, we are able to demonstrate the advantage of including PGx in clinical care for clinicians across different career levels ,There are so many advantages to equipping students and trainees with leading-edge tools and knowledge—the future is looking bright for precision medicine!"
Bernard Esquivel, MD, PhD, Chief Medical Officer of GenXys.
Auto-analysis of genetic information with other medication interaction points is helping to transform the centuries-old trial-and-error approach to prescribing to one of accuracy. PGx is all about personalized, safe, and appropriate medication options being available at any point of care. When integrated into smart algorithms with other data points, PGx is a critical part of proactive healthcare delivering precision medicine to everyone and leveling up healthcare inequality. MU is at the educational edge of changing day-to-day healthcare, and the partnership with GenXys is a model of commercial and academic integration that supports pending national legislation to provide better population healthcare, improve patient safety, and reduce healthcare costs.
About GenXys Health Care Systems
GenXys, with a presence across North America, provides the world's most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare's biggest challenges: inappropriate ("trial-and-error") prescribing. GenXys' clinical decision support software suite is in use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America. Ongoing global clinical studies are paving the way into geographical markets to enable GenXys to realize its vision of making every prescription better with its software to increase patient safety, improve population health, and reduce healthcare costs. https://www.genxys.com/
About Manchester University
Manchester University, in North Manchester and Fort Wayne, Ind., provides vibrant and transformative student experiences. Manchester University respects the infinite worth of every individual and graduates persons of ability and conviction who draw upon their education and faith to lead principled, productive, and compassionate lives that improve the human condition.
Penny AI | November 02, 2022
Penny AI, a global leader in data-driven direct sales enablement, is launching Learning Solutions, to empower social sellers with engagement-based micro-learning.Having raised $27 million in Series B funding, Penny is committed to investing in onboarding, continuous learning and social commerce to innovate how sellers are set up for success from day 1. Today’s launch is the industry’s first micro-learning experience embedded into a social sales enablement platform. Learning Solutions delivers big wins in small doses right in the flow of work.
To lead the development of the Learning Solutions product, Penny AI brought in Lauren Mason Carris, Ph.D. for her expertise in adult learning and skills-based personalized learning software. Lauren built out a product team to develop a behavior-based digital learning experience that marries how adults actually learn with what social sellers need in order to succeed.
“The hardest part of building a business is juggling learning while doing. Our new Learning Solutions delivers continuous training in the place of work (Penny) allowing sellers to learn about the industry, their company and business-building activities all while completing tasks. In effect sellers are learning while doing, For learning to work, it must be effective, relevant, just enough, and just in time. So that’s exactly what we’ve built.”
Lauren Mason Carris, VP of Product at Penny.
Learning Solutions is the natural next step to support social sellers as they build their business with Penny. It’s the first platform in the market that combines learning science with in-the-flow application of learned material. Learning Solutions include:
A best-in-class social selling curriculum
Gamified learning experience
Micro-doses of content
Skills application for revenue-focused tasks
Insights into learning retention and business impact
The ability for partners to turn their own content into behavior-based learning modules
Learning Solutions is designed to solve corporate and sellers onboarding challenges, ensuring every seller receives the right training at the right time, so they can successfully build a business. When I talk to anyone in the social sales community, be it corporate teams, leaders or sellers, one of the top challenges to organizational growth and long-term success is the staggering levels of seller churn because of ineffective onboarding and training,” says David Abbey, CEO & Co-Founder of Penny AI. Software done right changes lives and I believe that with Penny Learning Solutions we’ll see time to revenue for new sellers decrease, seller retention increase, efficiency and overall confidence increase, and as a result the life time value of the end customer increase.
Penny is an AI-powered platform built for modern social sellers. Focused on customer-centric processes that help the field build and grow their businesses with simple, repeatable steps in small pockets of time, Penny is customized to suit the unique business needs of each client.CEO & Co-founder, David Abbey and CTO & Co-founder, Chirs Noble created Penny to support David’s wife’s global social sales business when all other online tools were lacking the customer-centric approach so crucial to social sales success. Fast forward to today, Penny is transforming the social sales industry having identified a gap in the $200 billion industry for digital innovation that drives revenue growth, seller retention and customer satisfaction.
YuJa | January 23, 2023
Prairie State College recently announced that it is integrating with YuJa Panorama to avail of a digital platform for unlimited learning alternatives for its valuable learners.
YuJa Panorama is one of YuJa's high-impact media solutions that helps institutions deliver user-friendly video and media content. It makes things more accessible by automatically creating accessible versions of course materials in the background. It also has a visual accessibility gauge that lets creators know when their content has problems, a website accessibility tool that enables students to change how their user interface works, and detailed reports and scorecards. In addition, YuJa Panorama connects with D2L, the school's learning management system.
Prairie State College has emphasized accessibility in its mission, which is as follows: 'We provide unrestricted opportunities for learning suited to students' individual and collective needs and implement a fair process that recognizes their dignity.'
Nathan Arora, Chief Business Officer of YuJa, said, "YuJa is committed to providing tools that make accessibility easy to implement and manage from an institutional standpoint, and that drive inclusivity and promote learning for all students." He added, "Prairie State College is proactive about providing accessible content for all learners, and YuJa Panorama provides all the tools to help them meet their accessibility needs."
(Source - Business Wire)
YuJa is a prominent education and technology solutions company. It empowers organizations of all sizes with tools to motivate, engage, educate, and collaborate. It supports learning endeavors across various organizations, including higher education, K-12, government, healthcare, non-profit, and corporate. Its legal headquarters are in Delaware, with primary U.S. offices in Silicon Valley (California) and Canadian offices in Toronto.